The Effect of Adhesiolysis During Elective Abdominal Surgery on Per- and Postoperative Complication, Quality of Life and Socioeconomic Costs (LAPAD)

November 1, 2012 updated by: Radboud University Medical Center

A Prospective Study on the Effect of Adhesiolysis During Elective Laparotomy or Laparoscopy on Per- and Postoperative Complication, Quality of Life and Socioeconomic Costs

Official title:

LAPAD - A prospective study on the effect of adhesiolysis during elective laparotomy or laparoscopy on per- and postoperative complication, quality of life and socioeconomic costs

Background:

With improved surgical technology and ageing of the population the number of reoperations in the abdomen dramatically increases. The risk for a repeat laparotomy or laparoscopy is a high as 30% in the first ten years after a laparotomy. In over 95% of reoperations adhesiolysis is required to gain access to the abdominal cavity and operation area. Adhesiolysis significantly increases the risk for inadvertent organ damage, such as enterotomies, leading to higher morbidity, mortality and socioeconomic costs.

Purpose:

To define the impact of adhesiolysis on per- and postoperative complications, quality of life and socioeconomic costs.

Design:

Prospective observational study.

Primary outcomes:

  • adhesiolysis time
  • inadvertent enterotomy
  • seromuscular injury
  • miscellaneous organ damage
  • Serious adverse events of operation (anastomotic leakage, delayed diagnosed perforation, wound infection, abdominal infection, haemorrhage, pneumonia, urinary tract infection, abscess, fistula, sepsis, death)

Secondary outcomes:

  • Hospital stay
  • Intensive care admission
  • Reinterventions
  • In-hospital costs
  • Parenteral feeding
  • Short term readmissions (30 days)
  • Quality of life (Gastro- intestinal tract complaints, Short Form- 36(SF-36), DASI (Duke Activity Score Index(DASI) )

Estimated enrollment: 800 start study: 1 june 2008 Inclusion completion date: 1 june 2010 Estimated study completion date: 1 february 2011

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

752

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Gelderland
      • Nijmegen, Gelderland, Netherlands, 6500HB
        • Radboud University Nijmegen Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

patient undergoing elective laparotomy or laparoscopy in the department of surgery of the Radboud University Nijmegen Medical Centre (tertiary referral center).

Description

Inclusion Criteria:

  • Planned elective laparotomy or laparoscopy
  • Mentally competent
  • 18 years or older

Exclusion Criteria:

  • Operation cancelled
  • Bad quality of data

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
No adhesiolysis
All patient undergoing elective laparotomy or laparoscopy with no need for adhesiolysis during the procedure.
Adhesiolysis
All patient undergoing elective laparotomy or laparoscopy requiring adhesiolysis during the procedure.
Blunt or sharp dissection of adhesive tissue.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Inadvertent Enterotomy
Time Frame: Day of surgery (one day)
Every unintended and iatrogenic full thickness defect of the bowel.
Day of surgery (one day)
Seromuscular Injury
Time Frame: Day of surgery (one day)
Every visible damage to the serosa, without leakage or exposure of the bowel lumen.
Day of surgery (one day)
Miscellaneous Organ Damage
Time Frame: Day of surgery (one day)
Unintended iatrogenic damage to intra- peritoneal organs and structures other than bowel. E.g. Spleen, liver, pancreas or ureter.
Day of surgery (one day)
Serious Adverse Events
Time Frame: 30 days
Complications marked as SAE: anastomotic leakage, delayed diagnosed perforation, wound infection, abdominal infection, haemorrhage, pneumonia, urinary tract infection, abscess, fistula, sepsis, death
30 days
Adhesiolysis Time
Time Frame: Day of surgery (one day)
Time required to dissect adhesive tissue.
Day of surgery (one day)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hospital stay
Time Frame: From surgery to discharge
Number of days from surgery until discharge
From surgery to discharge
Reinterventions
Time Frame: 30 days after discharge
Emergency reoperation related to a complication of initial surgery within max. 30 days after discharge.
30 days after discharge
In- hospital Costs
Time Frame: From surgery to discharge
Direct costs comprising costs from operation, stay on ward and Intesive Care Unit, medication use, diagnostics.
From surgery to discharge
Parenteral Feeding
Time Frame: From surgery to discharge
Number of days that patient required parenteral feeding.
From surgery to discharge
Short term readmissions
Time Frame: 30 days after discharge
Readmissions to the hospital related to complication of surgery.
30 days after discharge
Quality of life
Time Frame: 6 months post surgery
Quality of life as measured with SF-36, Gastro- intestinal tract complaints and DASI index.
6 months post surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Harry van Goor, MD, PhD, FRCS, Radboud University Nijmegen Medical Center
  • Principal Investigator: Richard PG ten Broek, BsC, Radboud University Nijmegen Medical Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2008

Primary Completion (Actual)

February 1, 2011

Study Completion (Actual)

February 1, 2011

Study Registration Dates

First Submitted

November 4, 2010

First Submitted That Met QC Criteria

November 5, 2010

First Posted (Estimate)

November 7, 2010

Study Record Updates

Last Update Posted (Estimate)

November 2, 2012

Last Update Submitted That Met QC Criteria

November 1, 2012

Last Verified

September 1, 2010

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tissue Adhesions

Clinical Trials on Adhesiolysis

Subscribe